tiprankstipranks
Trending News
More News >
Torii Pharmaceutical Co Ltd (TRXPF)
OTHER OTC:TRXPF
US Market

Torii Pharmaceutical Co (TRXPF) Ratios

Compare
4 Followers

Torii Pharmaceutical Co Ratios

TRXPF's free cash flow for Q4 2024 was ¥0.29. For the 2024 fiscal year, TRXPF's free cash flow was decreased by ¥ and operating cash flow was ¥0.13. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
6.93 7.05 6.93 7.86 10.23
Quick Ratio
6.25 6.19 6.25 7.16 9.47
Cash Ratio
1.54 0.40 1.54 2.21 3.34
Solvency Ratio
0.29 0.34 0.29 0.26 0.36
Operating Cash Flow Ratio
0.18 -0.25 0.18 -0.01 -0.36
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.02 0.87
Net Current Asset Value
¥ 83.20B¥ 74.85B¥ 77.14B¥ 83.50B¥ 85.81B
Leverage Ratios
Debt-to-Assets Ratio
<0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
<0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Capital Ratio
<0.01 <0.01 <0.01 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.12 1.11 1.12 1.12 1.10
Debt Service Coverage Ratio
0.00 0.00 0.00 -0.51 -1.00
Interest Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
0.00 0.00 0.00 -0.09 -0.04
Interest Debt Per Share
18.65 8.68 18.65 17.30 10.47
Net Debt to EBITDA
-1.12 -0.82 -3.33 -5.33 -6.67
Profitability Margins
Gross Profit Margin
47.81%45.38%47.81%51.80%52.13%
EBIT Margin
11.70%10.24%11.70%10.15%10.14%
EBITDA Margin
12.22%10.67%12.22%10.74%11.24%
Operating Profit Margin
11.33%9.22%11.33%9.91%11.36%
Pretax Profit Margin
11.70%10.24%11.70%10.15%10.13%
Net Profit Margin
8.07%7.54%8.07%7.18%8.38%
Continuous Operations Profit Margin
8.07%7.54%8.07%7.18%8.38%
Net Income Per EBT
68.93%73.65%68.93%70.78%82.72%
EBT Per EBIT
103.29%111.06%103.29%102.38%89.17%
Return on Assets (ROA)
19.56%3.09%2.95%2.58%2.77%
Return on Equity (ROE)
24.19%3.43%3.31%2.88%3.04%
Return on Capital Employed (ROCE)
1.24%4.16%4.60%3.93%4.06%
Return on Invested Capital (ROIC)
1.15%3.06%3.16%2.96%3.48%
Return on Tangible Assets
19.63%3.10%2.96%2.59%2.78%
Earnings Yield
31.86%4.12%4.82%4.17%3.87%
Efficiency Ratios
Receivables Turnover
2.14 1.92 2.14 2.13 2.20
Payables Turnover
3.88 4.28 3.88 3.91 3.88
Inventory Turnover
2.84 2.78 2.84 2.58 2.79
Fixed Asset Turnover
21.43 26.08 21.43 22.61 23.47
Asset Turnover
0.37 0.41 0.37 0.36 0.33
Working Capital Turnover Ratio
0.60 0.71 0.60 0.55 0.48
Cash Conversion Cycle
244.55 236.40 204.81 218.84 202.63
Days of Sales Outstanding
213.50 190.40 170.69 170.98 165.92
Days of Inventory Outstanding
132.46 131.37 128.30 141.23 130.76
Days of Payables Outstanding
101.41 85.37 94.18 93.36 94.04
Operating Cycle
345.96 321.77 298.99 312.20 296.68
Cash Flow Ratios
Operating Cash Flow Per Share
86.13 -111.13 86.13 -5.55 -122.62
Free Cash Flow Per Share
76.13 -118.81 76.13 -18.87 -137.26
CapEx Per Share
10.00 7.69 10.00 13.31 14.64
Free Cash Flow to Operating Cash Flow
0.88 1.07 0.88 3.40 1.12
Dividend Paid and CapEx Coverage Ratio
1.49 -0.83 1.49 -0.09 -1.96
Capital Expenditure Coverage Ratio
8.61 -14.46 8.61 -0.42 -8.38
Operating Cash Flow Coverage Ratio
4.62 -12.80 4.62 -0.32 -11.71
Operating Cash Flow to Sales Ratio
0.05 -0.06 0.05 >-0.01 -0.08
Free Cash Flow Yield
48.84%-3.34%2.61%-0.66%-4.26%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
20.76 24.25 20.76 23.96 25.87
Price-to-Sales (P/S) Ratio
1.67 1.83 1.67 1.72 2.17
Price-to-Book (P/B) Ratio
0.69 0.83 0.69 0.69 0.79
Price-to-Free Cash Flow (P/FCF) Ratio
38.28 -29.92 38.28 -152.53 -23.46
Price-to-Operating Cash Flow Ratio
33.83 -31.99 33.83 -518.22 -26.26
Price-to-Earnings Growth (PEG) Ratio
1.23 5.50 1.23 -6.84 -0.30
Price-to-Fair Value
0.69 0.83 0.69 0.69 0.79
Enterprise Value Multiple
10.37 16.32 10.37 10.69 12.61
Enterprise Value
42.70B 95.15B 61.98B 53.96B 59.13B
EV to EBITDA
1.11 16.32 10.37 10.69 12.61
EV to Sales
0.99 1.74 1.27 1.15 1.42
EV to Free Cash Flow
1.02 -28.50 28.97 -101.80 -15.34
EV to Operating Cash Flow
1.00 -30.47 25.61 -345.87 -17.17
Tangible Book Value Per Share
4.23K 4.26K 4.23K 4.15K 4.08K
Shareholders’ Equity Per Share
4.24K 4.27K 4.24K 4.17K 4.10K
Tax and Other Ratios
Effective Tax Rate
0.31 0.26 0.31 0.29 0.17
Revenue Per Share
1.74K 1.94K 1.74K 1.67K 1.49K
Net Income Per Share
140.38 146.57 140.38 120.11 124.47
Tax Burden
0.73 0.74 0.69 0.71 0.83
Interest Burden
1.00 1.00 1.00 1.00 1.00
Research & Development to Revenue
0.07 0.06 0.03 0.02 0.01
SG&A to Revenue
0.00 0.23 0.03 0.00 0.00
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
1.13 -0.76 0.42 -0.03 -0.81
Currency in JPY
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis